Literature DB >> 47539

Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.

A Ferguson, T T MacDonald, J P McClure, R J Holden.   

Abstract

In an attempt to demonstrate local cell-mediated immunity (C.M.I.) to gliadin in patients with coeliac disease, fragments of jejunal-biopsy specimens were cultured in the presence and absence of alpha-gliadin and the culture-medium was assayed for its capacity to inhibit migration of normal human peripheral-blood leucocytes (i.e., for a migration-inhibition factor [M.I.F.]). No M.I.F. activity was detected in the culture-medium when biopsy specimens from patients with coeliac disease or controls were cultured without added antigen. However, an M.I.F. was secreted into the culture-medium when biopsy specimens from patients with coeliac disease were cultured with alpha-gliadin. These findings suggest that there is a population of lymphocytes which are sensitised to gliadin in the intestinal mucosa of patients with untreated coeliac disease. They support the theory that a local C.M.I. reaction to gliadin may be the cause of villous atrophy and crypt hyperplasia in coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47539     DOI: 10.1016/s0140-6736(75)91689-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  46 in total

1.  Functional characterization of Con A-responsive Lyt2-positive mouse small intestinal intraepithelial lymphocytes.

Authors:  S B Dillon; T T MacDonald
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  Deficiency of 6B11+ invariant NK T-cells in celiac disease.

Authors:  Randall H Grose; Fiona M Thompson; Adrian G Cummins
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

3.  The changing face of celiac disease.

Authors:  R Lad; K Jacobson
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

4.  Early biochemical responses of the small intestine of coeliac patients to wheat gluten.

Authors:  D S Bailey; A R Freedman; S C Price; D Chescoe; P J Ciclitira
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

5.  Serum interleukin-2-receptor in coeliac disease: response to treatment and gluten challenge.

Authors:  J E Crabtree; R V Heatley; L D Juby; P D Howdle; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

6.  Postnatal presentation [corrected] of coeliac disease.

Authors:  S Travis; P Ciclitira
Journal:  BMJ       Date:  1989-01-07

7.  The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes.

Authors:  G Malizia; L K Trejdosiewicz; G M Wood; P D Howdle; G Janossy; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

8.  Gluten specific suppressor T cell dysfunction in coeliac disease.

Authors:  G R Corazza; P Sarchielli; M Londei; M Frisoni; G Gasbarrini
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

9.  Cell-mediated immunity to gluten within the small intestinal mucosa in coeliac disease.

Authors:  P D Howdle; A W Bullen; M S Losowsky
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

Review 10.  Celiac disease: how complicated can it get?

Authors:  Jennifer May-Ling Tjon; Jeroen van Bergen; Frits Koning
Journal:  Immunogenetics       Date:  2010-07-27       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.